• Explore /
  • Poster
  • / Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer.

Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer.

Abstract Poster

Authors

Felix Feng

Felix Y Feng

Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Felix Y Feng , Matthew Raymond Smith , Fred Saad , Pooya Mobadersany , Shaozhou Ken Tian , Stephen S. F. Yip , Joel Greshock , Najat Khan , Margaret K. Yu , Sharon McCarthy , Sabine D. Brookman-May , Tamara Todorovic , Rikiya Yamashita , Huei-Chung Rebecca Huang , Timothy N Showalter , Akinori Mitani , Andre Esteva , Eric Jay Small

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT01946204

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5035)

DOI

10.1200/JCO.2023.41.16_suppl.5035

Abstract #

5035

Poster Bd #

129

Abstract Disclosures

Similar Posters

First Author: Pooya Mobadersany

First Author: Eric Jay Small

First Author: Mary-Ellen Taplin

First Author: Rahul Raj Aggarwal